NASDAQ:CGC Canopy Growth (CGC) Stock Price, News & Analysis $1.03 +0.04 (+4.06%) Closing price 04:00 PM EasternExtended Trading$1.03 0.00 (0.00%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Canopy Growth Stock (NASDAQ:CGC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Canopy Growth alerts:Sign Up Key Stats Today's Range$0.99▼$1.0550-Day Range$0.86▼$1.3852-Week Range$0.84▼$2.38Volume8.97 million shsAverage Volume13.46 million shsMarket Capitalization$416.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Canopy Growth Corporation is a leading Canadian cannabis company engaged in the production, distribution and sale of both medical and recreational cannabis products. Headquartered in Smiths Falls, Ontario, the company cultivates a diversified portfolio of offerings that includes dried flower, pre-rolled joints, oils, softgel capsules and edibles. Canopy Growth also markets derivative products such as beverages and wellness formulations under a range of brands, aiming to serve both patient and adult-use markets. The company operates through multiple subsidiaries, including Tweed Inc., Spectrum Therapeutics and Tokyo Smoke, each targeting distinct consumer segments. Its medical division supplies pharmaceutical-grade cannabis to patients in Canada and select international markets via Spectrum Therapeutics. On the adult-use side, brands like Tokyo Smoke and Doja focus on lifestyle-oriented products and retail experiences. Canopy additionally conducts research into cannabinoids and product formulations to expand its portfolio and address emerging consumer preferences. Founded in 2013 by Bruce Linton, Chuck Rifici and Neil Belot, Canopy Growth quickly grew through organic expansion and strategic acquisitions. In March 2020, the company appointed David Klein as Chief Executive Officer, entrusting him with the integration of acquired assets and execution of a global growth strategy. Klein brought extensive consumer packaged goods experience, having previously led Constellation Brands’ beverage business in Canada. Canopy Growth serves markets in Canada and maintains operations or partnerships across Europe, Australia and Latin America. The company has also established a presence in the United States through joint ventures and investments, positioning itself to capitalize on the evolving regulatory landscape. With a focus on innovation, international expansion and brand development, Canopy Growth aims to maintain its leadership in the rapidly changing cannabis industry.AI Generated. May Contain Errors. Read More Canopy Growth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks43rd Percentile Overall ScoreCGC MarketRank™: Canopy Growth scored higher than 43% of companies evaluated by MarketBeat, and ranked 625th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.6 / 5Analyst RatingHold Consensus RatingCanopy Growth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and 2 sell ratings.Amount of Analyst CoverageCanopy Growth has only been the subject of 3 research reports in the past 90 days.Read more about Canopy Growth's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Canopy Growth are expected to grow in the coming year, from ($0.36) to ($0.11) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Canopy Growth is -0.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Canopy Growth is -0.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCanopy Growth has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Canopy Growth's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.33% of the float of Canopy Growth has been sold short.Short Interest Ratio / Days to CoverCanopy Growth has a short interest ratio ("days to cover") of 1.26, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Canopy Growth has recently decreased by 5.06%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCanopy Growth does not currently pay a dividend.Dividend GrowthCanopy Growth does not have a long track record of dividend growth. News and Social Media4.3 / 5News Sentiment0.91 News SentimentCanopy Growth has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Canopy Growth this week, compared to 6 articles on an average week.Search Interest44 people have searched for CGC on MarketBeat in the last 30 days. This is an increase of 175% compared to the previous 30 days.MarketBeat Follows9 people have added Canopy Growth to their MarketBeat watchlist in the last 30 days. This is an increase of 800% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Canopy Growth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $14,048.00 in company stock.Percentage Held by Insiders0.16% of the stock of Canopy Growth is held by insiders.Percentage Held by Institutions3.33% of the stock of Canopy Growth is held by institutions.Read more about Canopy Growth's insider trading history. Receive CGC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CGC Stock News HeadlinesCanopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on ItMay 20 at 1:38 PM | finance.yahoo.comWhy Canopy Growth Corporation (CGC) Dipped More Than Broader Market TodayMay 18 at 7:56 PM | finance.yahoo.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.May 20 at 1:00 AM | Profits Run (Ad)Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026May 15, 2026 | finance.yahoo.comCanopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026May 15, 2026 | financialpost.comFCanopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026May 15, 2026 | businesswire.comIs Canopy Growth Stock Finally Setting Up for a Real Turnaround?May 15, 2026 | fool.comCanopy Growth Is One of the Market's Most Polarizing Stocks: 3 Scenarios for the Next 12 MonthsMay 14, 2026 | fool.comSee More Headlines CGC Stock Analysis - Frequently Asked Questions How have CGC shares performed this year? Canopy Growth's stock was trading at $1.14 at the beginning of the year. Since then, CGC stock has decreased by 9.6% and is now trading at $1.03. How were Canopy Growth's earnings last quarter? Canopy Growth Corporation (NASDAQ:CGC) posted its earnings results on Friday, February, 6th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.07. The company earned $90.39 million during the quarter, compared to analysts' expectations of $70.96 million. Canopy Growth had a negative net margin of 94.39% and a negative trailing twelve-month return on equity of 46.85%. Read the conference call transcript. When did Canopy Growth's stock split? Canopy Growth shares reverse split before market open on Wednesday, December 20th 2023.The 1-10 reverse split was announced on Wednesday, December 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Canopy Growth's major shareholders? Top institutional investors of Canopy Growth include Lazard Asset Management LLC (0.45%), Royal Bank of Canada (0.24%), Baader Bank Aktiengesellschaft (0.09%) and AdvisorShares Investments LLC (0.07%). Insiders that own company stock include Luc Mongeau, Christelle Gedeon, Judy Eun Joo Hong, Thomas Carlton Stewart, Willy Kruh, Theresa Yanofsky, M Shan Atkins, Joseph Bayern and David Angelo Lazzarato. View institutional ownership trends. How do I buy shares of Canopy Growth? Shares of CGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Canopy Growth own? Based on aggregate information from My MarketBeat watchlists, some other companies that Canopy Growth investors own include NVIDIA (NVDA), Meta Platforms (META), Alibaba Group (BABA), Micron Technology (MU), GE Aerospace (GE), BMO Capital Markets () and Stifel Nicolaus (). Company Calendar Last Earnings2/06/2026Today5/20/2026Next Earnings (Confirmed)6/15/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 CGC's financial health is in the Green zone, according to TradeSmith. CGC has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CGC CIK1737927 Webwww.canopygrowth.com Phone(855) 558-9333FaxN/AEmployees3,150Year Founded2014Profitability EPS (Trailing Twelve Months)($1.30) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$429.86 million Net Margins-94.39% Pretax Margin-95.11% Return on Equity-46.85% Return on Assets-28.95% Debt Debt-to-Equity Ratio0.30 Current Ratio5.34 Quick Ratio4.26 Sales & Book Value Annual Sales$225.65 million Price / Sales1.84 Cash FlowN/A Price / Cash FlowN/A Book Value$1.90 per share Price / Book0.54Miscellaneous Outstanding Shares404,120,000Free Float403,477,000Market Cap$416.24 million OptionableOptionable Beta0.78 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:CGC) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredAre we ignoring the same signal Wall Street ignored in 1929?In 1929, Irving Weiss spotted a systemic crisis hiding beneath record highs and shorted the market - turning $...Weiss Ratings | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredSaudi Arabia just broke its 50-year dollar arrangementSaudi Arabia has quietly walked away from its 1974 petrodollar agreement with the U.S. - the pact that require...Golden Portfolio | SponsoredFed story no one is tellingJ.P. Morgan's Private Bank quietly advised 333 billionaire families to move 60% of their portfolios into alter...TradeSmith | SponsoredThis stock has 30 days of quiet leftA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Canopy Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
